Skip to Content
Upcoming Events
Dec 10 - Dec 13, 2022
New Orleans, Louisiana

Title: Reprogramming macrophages using autologous hematopoietic stem cells as immunotherapy for glioblastoma: TEM-GBM study (NCT03866109)
Type: Poster
Presenter: Prof. Fabio Ciceri, Head of Hematology and Bone Marrow Transplantation Unit – San Raffaele Hospital

Past Events
Nov 15, 2022 at 4:00 PM CET

The Event is promoted by Amcham’s Bowling Green Bull, an initiative to connect Italian companies, entrepreneurs and top managers aiming for international growth and expansion in their interactions with U.S. financial markets and investors. Special Guest Karen Snow, Senior Vice President, Head of U.S. Listings and Revenue, Pierluigi Paracchi, CEO and Co-founder Genenta, Claudio Erba, CEO and Co-founder Docebo, Mauro Carobene, Chief Business Officer Kaleyra

Nov 8 - Nov 12, 2022
Boston, MA and virtual

Title: Autologous macrophage-based immunotherapy Induces a pro-inflammatory state in GBM tumor microenvironment - (TEM-GBM)
Type: Poster
Presenter: CMO Carlo Russo
Time: November 10-11, 9:00 AM – 8.30 PM ET

Oct 11 - Oct 14, 2022
Edinburgh, UK and virtual

Title: Genetically-modified hematopoietic stem cells as a one-time, systemic treatment for non-hematologic disorders
Type: Oral
Presenter: Bernhard Gentner, SR-TIGET, Milan and Co-founder of Genenta
Time: October 12, 11:10 AM -1:15 PM BST

Sep 19 - Sep 20, 2022
The Westin Copley Place Boston

Carlo Russo, CMO

Carlo Russo
Sep 15, 2022 at 10:40 AM EDT
New York, NY

Title: You Can't Get Anywhere without the CAR-t Keys or GMP Van: Why Manufacturing is Essential (panel presentation)


Pierluigi Paracchi, CEO
Carlo Russo, CMO
Richard Slansky, CFO